NATA Partners & Sponsors
Vifor Pharma Group is a global pharmaceuticals company. It aims to become global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. Vifor Pharma Group is listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).
For more information, visit www.viforpharma.com.
CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL), headquartered in Melbourne, Australia, employs nearly 20,000 people, delivering its life-saving therapies to people in more than 60 countries.
To learn more about Haemonetics, visit www.CSLBehring.com and follow us on www.Twitter.com/CSLBehring.
Haemonetics is a global healthcare company dedicated to providing innovative technology and software solutions for our customers. Our comprehensive portfolio of integrated devices, information management and consulting services offers solutions for hospitals, plasma and blood collectors and patients around the world. Collectively they help improve patient care, improve patient safety, and reduce costs.
To learn more about Haemonetics, visit www.haemonetics.com.
Instrumentation Laboratory (IL) develops and manufactures instruments, reagents and data management solutions, to help hospitals enhance patient care and efficiency. The IL booth features products from the IL Acute Care Diagnostics (ACD) portfolio, for laboratory and point-of-care (POC) testing, including ROTEM® sigma and delta viscoelastic testing systems, VerifyNowTM platelet aggregation systems and HemochronTM POC Hemostasis systems. Other key products in the IL ACD portfolio include GEM® PremierTM blood gas systems, AvoximeterTM CO-Oximeters and GEMweb® Plus Custom Connectivity. IL is a Werfen company.
For more information, visit www.instrumentationlaboratory.com.
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo rainbow® noninvasive and continuous total hemoglobin (SpHb®), acoustic respiration rate (RRa®), Masimo Patient SafetyNet™, SedLine® (EEG-based) Brain Function Monitors, and capnography monitors.
For more information, visit www.masimo.co.uk.
Annual Symposium Sponsors
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems. In the field of biosimilars, Fresenius Kabi develops products with a focus on oncology and autoimmune diseases.
With its corporate philosophy of “caring for life”, the company is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.
For more information, visit www.fresenius-kabi.com.
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease — faced by families and healthcare systems today. But no one can do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Founded in 1949 as a medical repair company, we’re now among the world’s largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in nearly 155+ countries. Join us in our commitment to take healthcare Further, Together.
Learn more at www.medtronic.eu.
The Nordic Group is a privately owned, pan-European pharmaceutical company, with a strong focus on the development and commercialization of niche hospital and orphan products. Nordic Group has a presence in 17 European countries, operating under the name of Nordic Pharma and Nordic Drugs. Nordic (which was already marketing an aprotinin product in UK) acquired rights to TRASYLOL® from Bayer in July 2012, worldwide excluding the United States. Additional information can be obtained at www.nordicpharmagroup.com.
The pharmaceutical firm Pharmanutra Spa was established in Pisa, Tuscany, with the aim to develop nutraceutical products and medical devices. Pharmanutra follows rigorous quality standards, always making careful selection of raw materials one of its top priorities. These are unique and very innovative ones. The firm focuses on studying and producing innovative formulations that are backed by in-depth scientific research. An innovative product like SiderAL, oral sucrosomial iron supplement, quickly became the leading product in its market segment, first in Italy and subsequently in other countries. Since 2005 Pharmanutra has been developing and marketing its own range of products through a team of scientific representatives and medical detailing.
SORIN GROUP is a global leader in the treatment of cardiovascular diseases. Committed to blood management for more than 30 years, and operating in more than 80 countries, Sorin Group has treated more than 6.5 million patients with its autotransfusion devices. At NATA, Sorin Group is proud to exhibit Sorin XTRA®, its sixth-generation autotransfusion system. Sorin XTRA® is a compact, ergonomic, robust autotransfusion device with an attractive design. Sorin XTRA® combines and improves the best features of current Sorin autotransfusion devices, introducing further innovation through C5 and S5-like design, graphic color touch screen user interface and advanced data management capabilities.
For more information, visit www.sorin.com.